Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
ALI HEALTH Slips 3% Below HKD4 to 1Yr+ Low; G Sachs Cuts TP to HKD4.2
Recommend 28 Positive 27 Negative 28 |
||||
|
||||
|
ALI HEALTH (00241.HK) opened 0.98% lower today (19th) and hit a trough of HKD3.96, marking an over one-year low. It last printed at HKD3.97, down 3.17%, with 78.7555 million shares traded, involving HKD314 million. In its report, Goldman Sachs said that ALI HEALTH's 2HFY26 results were mixed. The broker kept its Neutral rating, noting that revenue growth was mainly driven by pharmaceuticals. However, sour competition is expected to give rise to slower growth than JD HEALTH (06618.HK). The broker forecast ALI HEALTH's revenue for FY2027 ending March to grow 13% YoY, compared with an estimated 18% revenue growth for JD HEALTH in 2026. Given weaker-than-expected growth in its third-party platform business, gross margin volatility stemming from revenue mix, and incremental investments in AI and innovative drugs, Goldman Sachs lowered its revenue forecasts for FY2027-28 on ALI HEALTH by 2% and cut its adjusted net profit forecasts for the same period by 18%, while introducing FY2029 projections. The broker reduced its 12-month TP from HKD4.8 to HKD4.2. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
